SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling by Ravikumar Sitapara, Chuluunbaatar Sugarragchaa, Lawrence S. Zisman

Get full text

Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension by Anna Hemnes, Alexander M.K. Rothman, Andrew J. Swift, Lawrence S. Zisman

Get full text

Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension by Mariana Faria-Urbina, Keith T. Ung, Laurie Lawler, Lawrence S. Zisman, Aaron B. Waxman

Get full text

Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension by Ravikumar Sitapara, TuKiet T. Lam, Aneta Gandjeva, Rubin M. Tuder, Lawrence S. Zisman

Get full text

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension by Soni Savai Pullamsetti, Ravikumar Sitapara, Robin Osterhout, Astrid Weiss, Laura L. Carter, Lawrence S. Zisman, Ralph Theo Schermuly

Get full text

Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics by William T Abraham, Mary V Raynolds, David B Badesch, Kristine M Wynne, Bertron M Groves, Robert L Roden, Alastair D Robertson, Brian D Lowes, Lawrence S Zisman, Norbert F Voelkel, Michael R Bristow, M Benjamin Perryman

Get full text